Latest Issue

Volume 9 Issue 3

Paper of the Month

Atacicept in patients with rheumatoid arthritis and an inadequate response to tumor necrosis factor antagonist therapy: results of a Phase II, randomized, placebo-controlled, dose-finding trial

Genovese MC, Kinnman N, de La Bourdonnaye G et al.
Arthritis Rheum 2011;63:1793–803. This article reported a Phase II study of atacicept in the patients with rheumatoid arthritis who had failed tumor necrosis factor antagonist therapy. The efficacy, safety, and biological activity of three doses of atacicept were described.
» Read an expert review of this paper

Webcast

Latest news

  • Home
  • Home
  • Home
  • Home
  • Home
  • Home

READER POLL

IJAR Poll 3
How have the “Treat-to-Target” recommendations affected your day-to-day practice?






Powered by NetPolls

READER SURVEY

SUBMIT AN ARTICLE

OTHER REMEDICA JOURNALS

COMPASS PUBMED SEARCH

Enter your search terms below to search pubmed for articles